Table 1.
Clinicopathological characteristics of the cohort of the patients with squamous cell carcinoma (oral cavity and other locations)
| Characteristic | Categories | Number (%) |
|---|---|---|
| Gender | Male | 102 (72.8) |
| Female | 38 (27.1) | |
| Squamous cell carcinoma histology (by anatomic location) | Oral cavity | 93 (66.4) |
| Larynx | 25 (17.9) | |
| Pharynx | 5 (3.6) | |
| Other locations (skin, cervix) | 15 (10.7) | |
| Unknown | 2 (1.4) | |
| Cancer grade | G1 | 24 (17.1) |
| G2 | 85 (60.7) | |
| G3 | 16 (11.4) | |
| Unknown | 15 (10.7) | |
| Tumor (pT) stage | pT1 | 41 (29.3) |
| pT2 | 39 (27.9) | |
| pT3 | 21 (15.0) | |
| pT4 | 30 (21.4) | |
| Unknown | 9 (6.4) | |
| HPV (E6) oncoprotein expression (IHC) | Oral cavity | 21 (44.6) |
| Larynx | 14 (87.5) | |
| Pharynx | 4 (80) | |
| Other locations (skin, cervix) | 1 (16.6) | |
| EBV (LMP1) oncoprotein expression (IHC) | Oral cavity | 35 (76) |
| Larynx | 1 (33.3) | |
| Pharynx | 3 (100) | |
| Other locations (skin, cervix) | 2 (40) | |
| HPV (E6) oncoprotein expression (PCR) | Oral cavity | 29 (45.3) |
| Larynx | 17 (70.8) | |
| Pharynx | 3 (60) | |
| Other locations (skin, cervix) | 3 (60) | |
| EBV (LMP1) oncoprotein expression (PCR) | Oral cavity | 50 (78.1) |
| Larynx | 14 (21.8) | |
| Pharynx | 1 (4.1) | |
| Other locations (skin, cervix) | 3 (60) |